SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10QSB - Optional form for quarterly and transition reports of small business issuers:
SEC Accession No. 0000812796-05-000016
Filing Date
2005-08-15
Accepted
2005-08-15 15:47:49
Documents
6
Period of Report
2005-08-12

Document Format Files

Seq Description Document Type Size
1 DOR2Q05 dor2q05.htm 10QSB 371467
2 CEOCERT2Q05 ceocert.htm EX-31.1 11983
3 CFOCERT2Q05 cfocert2q05.htm EX-31.2 11990
4 CEO906-2Q05 ceo906-2q05.htm EX-32.1 5880
5 CFOCERT906-2Q05 cfocert906-2q05.htm EX-32.2 5768
6 RISKFACTORS2Q05 riskfactors2q05.htm EX-99.1 66185
  Complete submission text file 0000812796-05-000016.txt   474880
Mailing Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139
Business Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139 305-534-3383
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10QSB | Act: 34 | File No.: 000-16929 | Film No.: 051026440
SIC: 2834 Pharmaceutical Preparations